Recevez les dernières nouvelles sur l'action Quest Diagnostics avec des mises à jour sur les tendances du marché, les données financières et les analyses de Benzinga. Restez informé des performances de DGX

Dernières nouvelles pour

QUEST DIAGNOSTICS INC

Quest Diagnostics

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Quest Diagnostics Incorporated Common Stock

Quest Diagnostics Inc

Digi Power X Inc. - Common Subordinate Voting Shares

Digi Power X Inc

Press Releases

Fentanyl Positivity Is More Than Seven Times Higher in Random Tests vs. Pre-Employment Drug Screening, Finds 2025 Quest Diagnostics Drug Testing Index

Quest Diagnostics Launches Advanced Pharmacogenomics (PGx) Offering

Quest Diagnostics to Speak at the Jefferies Healthcare Services Conference

WHOOP to Bring Clinical Lab Testing from Quest Diagnostics to the WHOOP App

Haystack Oncology and Rutgers Cancer Institute Collaborate in a Clinical Study to Examine Haystack MRD as a Guide for Post-Surgical Treatment for Lung Cancer

News

Contracts

Quest Diagnostics to Improve Laboratory Testing Experience with Industry-First Epic Collaboration

Guardant Health and Quest Diagnostics Announce Strategic Collaboration to Broaden Access to Guardant's Shield™ Blood-based Screening Test in the United States

Quest Diagnostics to Release Third Quarter 2025 Financial Results on October 21, 2025

WHOOP Launches Clinician-Reviewed Advanced Labs, Unlocking a Comprehensive View of Human Health

Earnings

Quest Diagnostics Reports Third Quarter 2025 Financial Results; Raises Guidance for Full Year 2025

Addus HomeCare Corporation - Common Stock

Addus HomeCare

Astrana Health

Aveanna Healthcare Holdings Inc. - Common Stock

Aveanna Healthcare Hldgs

BrightSpring Health Services, Inc. - Common Stock

BrightSpring Health

BrightSpring Health Services, Inc. - Tangible Equity Unit

Chemed

Cigna Group

CorVel

CVS Health

DaVita

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)

Fresenius Medical Care

Guardant Health

Hims & Hers Health, Inc. Class A Common Stock

Hims & Hers Health

Hinge Health

LifeStance Health Group, Inc. - Common Stock

LifeStance Health Gr

Labcorp Hldgs

Pediatrix Medical Group, Inc. Common Stock

Pediatrix Medical Group

NeoGenomics

Omada Health

Option Care Health

OPKO Health

Premier

Privia Health Gr

RadNet

GeneDx Holdings Corp. - Class A Common Stock

GeneDx Holdings

Barclays

Truist Securities

Leerink Partners

Jefferies

Screenshot 2025-04-15 at 7.03.21 PM

Biotech

MYNZ

Mainz Biomed Narrows Its Losses, Grows Revenue For Full Year 2024

Screenshot 2024-12-19 at 7.13.05 PM

General

Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S.

Comments

Quest Diagnostics Actualités boursières

Actualités

Dernières nouvelles pour

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL